Literature DB >> 21335510

Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study.

Liam Bourke1, Helen Doll, Helen Crank, Amanda Daley, Derek Rosario, John M Saxton.   

Abstract

BACKGROUND: Healthy lifestyle behaviors could have a role in ameliorating some of the adverse effects of androgen suppression therapy (AST) in men with prostate cancer. The primary aim of this study was to assess the feasibility of a tapered supervised exercise program in combination with dietary advice in men with advanced prostate cancer receiving AST.
METHODS: Advanced prostate cancer patients receiving AST for a minimum of 6 months were randomized to a 12-week lifestyle program comprising aerobic and resistance exercise, plus dietary advice (n = 25), or standard care (n = 25). Exercise behavior, dietary macronutrient intake, quality of life, fatigue, functional fitness, and biomarkers associated with disease progression were assessed at baseline, after the intervention, and at 6 months.
RESULTS: The lifestyle group showed improvements in exercise behavior (P < 0.001), dietary fat intake (P = 0.001), total energy intake (P = 0.005), fatigue (P = 0.002), aerobic exercise tolerance (P < 0.001), and muscle strength (P = 0.033) compared with standard care controls. Although a high rate of attrition (44%) was observed at 6 months, the improvements in key health outcomes were sustained. No effects on clinical prostate cancer disease markers were observed.
CONCLUSIONS: This preliminary evidence suggests that pragmatic lifestyle interventions have potential to evoke improvements in exercise and dietary behavior, in addition to other important health outcomes in men with advanced prostate cancer receiving AST. IMPACT: This study shows for the first time that pragmatic lifestyle interventions are feasible and could have a positive impact on health behaviors and other key outcomes in men with advanced prostate cancer receiving AST.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21335510     DOI: 10.1158/1055-9965.EPI-10-1143

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

1.  Physical activity levels of cancer survivors in Canada: findings from the Canadian Community Health Survey.

Authors:  S E Neil; C C Gotay; K L Campbell
Journal:  J Cancer Surviv       Date:  2014-03       Impact factor: 4.442

2.  A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer.

Authors:  James R Hébert; Thomas G Hurley; Brook E Harmon; Sue Heiney; Christine J Hebert; Susan E Steck
Journal:  Cancer Epidemiol       Date:  2011-10-20       Impact factor: 2.984

Review 3.  The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review.

Authors:  T Hasenoehrl; M Keilani; T Sedghi Komanadj; M Mickel; M Margreiter; M Marhold; R Crevenna
Journal:  Support Care Cancer       Date:  2015-05-24       Impact factor: 3.603

4.  A Walking Intervention Among Men With Prostate Cancer: A Pilot Study.

Authors:  Claire H Pernar; Katja Fall; Jennifer R Rider; Sarah C Markt; Hans-Olov Adami; Sven-Olof Andersson; Unnur Valdimarsdottir; Ove Andrén; Lorelei A Mucci
Journal:  Clin Genitourin Cancer       Date:  2017-05-31       Impact factor: 2.872

Review 5.  Physical activity and cancer survivorship.

Authors:  David O Garcia; Cynthia A Thomson
Journal:  Nutr Clin Pract       Date:  2014-10-21       Impact factor: 3.080

Review 6.  Exercise interventions on health-related quality of life for people with cancer during active treatment.

Authors:  Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

7.  Physical activity and advanced cancer: the views of oncology and palliative care physicians in Ireland.

Authors:  G Sheill; E Guinan; L O Neill; D Hevey; J Hussey
Journal:  Ir J Med Sci       Date:  2017-08-31       Impact factor: 1.568

8.  Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study.

Authors:  Daniel Santa Mina; Michael K Connor; Shabbir M H Alibhai; Paul Toren; Crissa Guglietti; Andrew G Matthew; John Trachtenberg; Paul Ritvo
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

9.  A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer.

Authors:  Roisin F O'Neill; Farhana Haseen; Liam J Murray; Joe M O'Sullivan; Marie M Cantwell
Journal:  J Cancer Surviv       Date:  2015-04-28       Impact factor: 4.442

10.  First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH.

Authors:  Kagan Griffin; Ilona Csizmadi; Lauren E Howard; Gina-Maria Pomann; William J Aronson; Christopher J Kane; Christopher L Amling; Matthew R Cooperberg; Martha K Terris; Jennifer Beebe-Dimmer; Stephen J Freedland
Journal:  Cancer Causes Control       Date:  2019-01-30       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.